share_log

Xilio Therapeutics | 8-K: Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results

SEC announcement ·  May 14 19:49
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.